Publications

2012

Identification and characterization of the Plasmodium falciparum RhopH2 ortholog in Plasmodium vivax. Wang B, Lu F, Cheng Y, Li J, Ito D, Sattabongkot J, Tsuboi T, Han ET. Parasitol Res. 2012 Oct 25.

Plasmodium falciparum Gametocyte Development 1 (Pfgdv1) and Gametocytogenesis Early Gene Identification and Commitment to Sexual Development. Eksi S, Morahan BJ, Haile Y, Furuya T, Jiang H, Ali O, Xu H, Kiattibutr K, Suri A,Czesny B, Adeyemo A, Myers TG, Sattabongkot J, Su XZ, Williamson KC. PLoS Pathog. Oct;8(10). 2012.

Immunity to Malaria in Plasmodium vivax Infection: A Study in Central China. Jangpatarapongsa K, Xia H, Fang Q, Hu K, Yuan Y, Peng M, Gao Q, Sattabongkot J, Cui L, Li B,Udomsangpetch R. PLoS One. 2012;7(9).

Longitudinal in vitro surveillance of Plasmodium falciparum sensitivity to common anti-malarials in Thailand between 1994 and 2010. Parker D, Lerdprom R, Srisatjarak W, Yan G, Sattabongkot J, Wood J, Sirichaisinthop J, Cui L. Malar J. 11(1): 290. 2012.

Use of a Rhesus Plasmodium cynomolgi Model to Screen for Anti-Hypnozoite Activity of Pharmaceutical Substances. Deye GA, Gettayacamin M, Hansukjariya P, Im-Erbsin R, Sattabongkot J, Rothstein Y, Macareo L, Fracisco S, Bennett K, Magill AJ, Ohrt C. Am J Trop Med Hyg. 86(6):931-5. 2012.

Cloning of a trypsin-like serine protease and expression patterns during Plasmodium falciparum invasion in the mosquito, Anopheles dirus (Peyton and Harrison). Sriwichai P, Rongsiryam Y, Jariyapan N, Sattabongkot J, Apiwathnasorn C, Nacapunchai D, Paskewitz S. Arch Insect Biochem Physiol. 2012 May 24.

Variable clinical responses of a scrub typhus outbred mouse model to feeding byOrientia tsutsugamushi infected mites. Lurchachaiwong W, Monkanna T, Leepitakrat S, Ponlawat A, Sattabongkot J, Schuster AL, McCardle PW, Richards AL. Exp Appl Acarol. 2012.

Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt. Takahashi N, Tanabe K, Tsukahara T, Dzodzomenyo M, Dysoley L, Khamlome B, Sattabongkot J,Nakamura M, Sakurai M, Kobayashi J, Kaneko A, Endo H, Hombhanje F, Tsuboi T, Mita T. 11(1):92. 2012.

Natural Infection of Plasmodium falciparum Induces Inhibitory Antibodies against Gametocyte Development in Human Hosts. Tonwong N, Sattabongkot J, Tsuboi T, Iriko H, Takeo S, Sirichaisinthop J, Udomsangpetch R. Jpn J Infect Dis;65(2):152-6. 2012 Mar.

Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant vaccine candidate in combination with second-generation adjuvants in mice. Lumsden JM, Nurmukhambetova S, Klein JH, Sattabongkot J, Bennett JW, Reed SG, Ockenhouse CF, Howard RF, Polhemus ME, Yadava A. Vaccine. 2012.

Pv12, a 6-Cys antigen of Plasmodium vivax, is localized to protein the merozoite rhoptry. Li J, Ito D, Chen JH, Lu F, Cheng Y, Wang B, Ha KS, Cao J, Torii M, Sattabongkot J, Tsuboi T, Han ET. Parasitol Int. 2012.

Stable allele frequency distribution of the polymorphic region of SURFIN(4.2) in Plasmodium falciparum isolates from Thailand. Kaewthamasorn M, Yahata K, Alexandre JS, Xangsayarath P, Nakazawa S, Torii M, Sattabongkot J, Udomsangpetch R, Kaneko O. Parasitol Int;61(2):317-23. 2012 Jun.

Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes. Sakamoto H, Takeo S, Maier AG, Sattabongkot J, Cowman AF, Tsuboi T. Vaccine. 30(11):1972-80. 2012.

Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate. Tachibana M, Sato C, Otsuki H, Sattabongkot J, Kaneko O, Torii M, Tsuboi T. Vaccine.;30(10):1807-12. 2012.

Investigations on the role of a lysozyme from the malaria vector Anopheles dirus during malaria parasite development. Lapcharoen P, Komalamisra N, Rongsriyam Y, Wangsuphachart V, Dekumyoy P, Prachumsri J, Kajla MK, Paskewitz SM, Dev Comp Immunol 36: 104-11. 2012.

Correlation of Pfg377 ortholog gene expression of Plasmodium vivax and mosquito infection. Chansamut N, Buates S, Takhampunya R, Udomsangpetch R, Bantuchai S, Sattabongkot J. Trop Med Int Health. 2012.

Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes. Sakamoto H, Takeo S, Maier AG, Sattabongkot J, Cowman AF, Tsuboi T. Vaccine. 2012 Jan 13.

Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate. Tachibana M, Sato C, Otsuki H, Sattabongkot J, Kaneko O, Torii M, Tsuboi T. Vaccine. 2012 Jan 10.

Investigations on the role of a lysozyme from the malaria vector Anopheles dirus during malaria parasite development. Lapcharoen P, Komalamisra N, Rongsriyam Y, Wangsuphachart V, Dekumyoy P, Prachumsri J, Kajla MK, Paskewitz SM. Dev Comp Immunol;36(1):104-11. 2012 Jan.

2011

Stable allele frequency distribution of the polymorphic region of SURFIN(4.2) in Plasmodium falciparum isolates from Thailand. Kaewthamasorn M, Yahata K, Alexandre JS, Xangsayarath P, Nakazawa S, Torii M, Sattabongkot J, Udomsangpetch R, Kaneko O. Parasitol Int. 2011 Dec 27.

Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Meister S, Plouffe DM, Kuhen KL, Bonamy GM, Wu T, Barnes SW, Bopp SE, Borboa R, Bright AT, Che J, Cohen S, Dharia NV, Gagaring K, Gettayacamin M, Gordon P, Groessl T, Kato N, Lee MC, McNamara CW, Fidock DA, Nagle A, Nam TG, Richmond W, Roland J, Rottmann M, Zhou B, Froissard P, Glynne RJ, Mazier D, Sattabongkot J, Schultz PG, Tuntland T, Walker JR, Zhou Y, Chatterjee A, Diagana TT, Winzeler EA. Science;334(6061):1372-7. 2011 Dec 9.

Evaluation of loop-mediated isothermal amplification (LAMP) for malaria diagnosis in a field setting. Sirichaisinthop J, Buates S, Watanabe R, Han ET, Suktawonjaroenpon W, Krasaesub S, Takeo S, Tsuboi T, Sattabongkot J. Am J Trop Med Hyg;85(4):594-6. 2011 Oct.

Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen. Arumugam TU, Takeo S, Yamasaki T, Thonkukiatkul A, Miura K, Otsuki H, Zhou H, Long CA, Sattabongkot J, Thompson J, Wilson DW, Beeson JG, Healer J, Crabb BS, Cowman AF, Torii M, Tsuboi T. Infect Immun;79(11):4523-32. 2011 Nov.

In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China. Lu F, Gao Q, Chotivanich K, Xia H, Cao J, Udomsangpetch R, Cui L, Sattabongkot J. Am J Trop Med Hyg;85(2):197-201. 2011 Aug.

Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development. Miyata T, Harakuni T, Tsuboi T, Sattabongkot J, Ikehara A, Tachibana M, Torii M, Matsuzaki G, Arakawa T. Infect Immun;79(10):4260-75. 2011 Oct.

Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta). Dow GS, Gettayacamin M, Hansukjariya P, Imerbsin R, Komcharoen S, Sattabongkot J, Kyle D, Milhous W, Cozens S, Kenworthy D, Miller A, Veazey J, Ohrt C. Malar J;10:212. 2011 Jul 29.

Permanent Genetic Resources added to Molecular Ecology Resources Database 1 April 2011-31 May 2011. Molecular Ecology Resources Primer Development Consortium, Bonizzoni M, Bourjea J, Chen B, Crain BJ, Cui L, Fiorentino V, Hartmann S, Hendricks S, Ketmaier V, Ma X, Muths D, Pavesi L, Pfautsch S, Rieger MA, Santonastaso T, Sattabongkot J, Taron CH, Taron DJ, Tiedemann R, Yan G, Zheng B, Zhong D. Mol Ecol Resour;11(5):935-6. 2011 Sep.

N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity. Tachibana M, Wu Y, Iriko H, Muratova O, MacDonald NJ, Sattabongkot J, Takeo S, Otsuki H, Torii M, Tsuboi T. Clin Vaccine Immunol;18(8):1343-50. 2011 Aug.

Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion. Lumsden JM, Pichyangkul S, Srichairatanakul U, Yongvanitchit K, Limsalakpetch A, Nurmukhambetova S, Klein J, Bertholet S, Vedvick TS, Reed SG, Sattabongkot J, Bennett JW, Polhemus ME, Ockenhouse CF, Howard RF, Yadava A. Infect Immun;79(9):3492-500. 2011 Sep.

Determination of the Plasmodium vivax schizont stage proteome. Roobsoong W, Roytrakul S, Sattabongkot J, Li J, Udomsangpetch R, Cui L. J Proteomics;74(9):1701-10. 2011 Aug 24.

Challenges and prospects for malaria elimination in the Greater Mekong Subregion. Cui L, Yan G, Sattabongkot J, Chen B, Cao Y, Fan Q, Parker D, Sirichaisinthop J, Su XZ, Yang H, Yang Z, Wang B, Zhou G. Acta Trop. 2011 Apr 14.

Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax. Doi M, Tanabe K, Tachibana S, Hamai M, Tachibana M, Mita T, Yagi M, Zeyrek FY, Ferreira MU, Ohmae H, Kaneko A, Randrianarivelojosia M, Sattabongkot J, Cao YM, Horii T, Torii M, Tsuboi T. Vaccine;29(26):4308-15. 2011 Jun 10.

Malaria in the Greater Mekong Subregion: Heterogeneity and complexity. Cui L, Yan G, Sattabongkot J, Cao Y, Chen B, Chen X, Fan Q, Fang Q, Jongwutiwes S, Parker D, Sirichaisinthop J, Kyaw MP, Su XZ, Yang H, Yang Z, Wang B, Xu J, Zheng B, Zhong D, Zhou G. Acta Trop. 2011 Mar 5.

Adenovirus-vectored Plasmodium vivax ookinete surface protein, Pvs25, as a potential transmission-blocking vaccine. Miyata T, Harakuni T, Sugawa H, Sattabongkot J, Kato A, Tachibana M, Torii M, Tsuboi T, Arakawa T. Vaccine;29(15):2720-6. 2011 Mar 24.

Genetic polymorphism of Plasmodium vivax msp1p, a paralog of merozoite surface protein 1, from worldwide isolates. Wang Y, Kaneko O, Sattabongkot J, Chen JH, Lu F, Chai JY, Takeo S, Tsuboi T, Ayala FJ, Chen Y, Lim CS, Han ET. Am J Trop Med Hyg;84(2):292-7. 2011 Feb.

Detection of an antibody against Plasmodium vivax in residents of Gimpo-si, South Korea, using an indirect fluorescent antibody test. Lee WJ, Kim HH, Hwang SM, Park MY, Kim NR, Cho SH, In TS, Kim JY, Sattabongkot J, Sohn Y, Kim H, Lee JK, Lee HW. Malar J;10:19. 2011 Jan 31.